The Latest Breaking News from Lupus

Rocks to Selena Gomez: My Mind & Me – the seven best films to watch on TV this week

Bukky Bakray stars in Sarah Gavron’s hugely engaging drama about a young girl struggling to take care of her brother after being abandoned by their mother, while the ex-child star talks about her struggles with lupus and depression

The Guardian - UK · Oct 28, 2022

The new state of healthcare in America: one for men and a worse one for women

After Roe v Wade, women in anti-abortion states can’t access life-saving medication for everything from chronic pain to lupus to ulcers

The Guardian - US · Oct 12, 2022

Louise Thompson shares worrying health update after posting snap of severe facial rash

Former Made In Chelsea star Louise Thompson is riddled with concerns that she has Lupus after her face broke out in an angry rash as she felt as though her 'immune system was attacking her'

Daily Mirror · Oct 5, 2022

Disability advocates call for better support for people in rural, regional and remote NSW

Pauline Follett, who lives with cerebral lupus, has had two National Disability Insurance Scheme applications rejected within three years. According to a Disability Advocacy NSW report, people in remote areas of NSW face challenges in providing the evidence required.

ABC News · Aug 7, 2022

Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jul 28, 2022

Recap of Wednesday's Biotech Catalysts - End of The Day Summary

IDEAYA Biosciences (NASDAQ:IDYA) has entered into a clinical trial collaboration and supply agreement with Amgen Inc. to evaluate the efficacy and safety of IDE397 with Amgen's AMG 193  in a Phase 1 clinical trial. IDEAYA shares traded in a range of $14.59 to $15.82 on a day volume of 130.58…

Benzinga · Jul 27, 2022

What is lupus? New treatment could end the need for lifelong medication

Three patients have undergone CAR T-cell therapy, which genetically alters their immune system to protect their organs

Evening Standard · Jul 27, 2022

Post-Roe, many autoimmune patients lose access to 'gold standard' drug

Six days after the Supreme Court struck down the right to abortion, lupus patient Becky Schwarz got an unexpected message from her rheumatologist.

Los Angeles Times · Jul 14, 2022

Why Is Kezar Life Sciences Surging By 78%? 25 Stocks Moving In Tuesday's Pre-Market Session

Gainers Kezar Life Sciences, Inc. (NASDAQ: KZR) rose 78% to $10.29 in pre-market trading after the company reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

Benzinga · Jun 28, 2022

Kezar Life Shares Shoot Higher After Positive Results From Mid-Stage Study Of Kidney Disease Candidate

Kezar Life Sciences, Inc. (NASDAQ: KZR) reported positive topline results from the MISSION Phase 2 clinical trial evaluating zetomipzomib in patients with active lupus nephritis (LN).

Benzinga · Jun 27, 2022